7Z6.F Coegin Pharma AB

Healthcare Biotechnology Frankfurt Exchange
0.1625 EUR
Close of Nov 12, 2026
0.1400 0.4450
Market cap
EUR 4.99M
P/E
-
P/B
10.08x
ROE
-355.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 7Z6.F undervalued?

Graham number

The Graham number of Coegin Pharma AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Coegin Pharma AB fundamental analysis

No fundamental analysis for Coegin Pharma AB yet.

Coegin Pharma AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Coegin Pharma AB

Coegin Pharma AB (publ), a biotechnology company, develops and commercializes cosmetic technologies for hair and skin in Sweden. Its flagship product is Follicopeptide, a patented, clinically developed peptide technology targeting hair thinning; and NPP-4, a cosmetic peptide product designed to enhance skin tone without UV exposure or chemicals. The company also develops FOL026, a peptide drug candidate for the treatment of myocardial infarction; AVX420, a drug candidate for…

Full company profile